110550-27-1

Upstream product

• 100-39-0 benzyl bromide 
• 102997-58-0 (1R,2R,3S)-tris(phenylmethoxy)-6S-hydroxy-cyclohex-4-ene 
• 138258-55-6 (1S,2R,3R,4S)-1,2,3,4,tetrahydroxy-5-cyclohexene 
• 195873-73-5 (3S,4R,5R)-tribenzyloxy-(6S)-hydroxyocta-1,7-diene 
• 195873-64-4 3,4,5-tri-O-benzyl-1,2-dideoxy-D-xylohept-1-enitol 
• 195873-65-5 (2S,3R,4S)-2,3,4-Tris-benzyloxy-hex-5-enal 
• 18039-26-4 2,3,4-tri-O-benzyl-D-xylopyranose 
• 6195-66-0 (3S,4R,5R,6S)-3,4,5,6-Tetrakis-benzyloxy-cyclohexane-1,2-diol 

Downstream Products

• 1342804-97-0 (3aS,4S,5R,6R,7S,7ar)-4,5,6,7-tetrakis(benzyloxy)-1,3-dinonyl-hexahydro-1H-benzo[d]imidazol-2(3H)-one 
• 1310554-99-4 (1S,2R,3S,4R,5R,6S)-3,4,5,6-tetrakis(benzyloxy)-N₁,N₂-dinonylcyclohexane-1,2-diamine 
• 1310555-00-0 (3aS,4S,5R,6R,7S,7ar)-4,5,6,7-tetrakis(benzyloxy)-hexahydro-1H-benzo[d]imidazol-2(3H)-one 
• 1310555-01-1 ((1S,2R,3R,4S,5S,6R)-5,6-bis(nonyloxy)cyclohexane-1,2,3,4-tetrayl)tetrakis(oxy)tetrakis(methylene)tetrabenzene 
• 1310554-90-5 (1R,2S,3S,4R,5R,6S)-5,6-bis(nonyloxy)cyclohexane-1,2,3,4-tetraol 
• 1310554-96-1 C₆₂H₉₀N₂O₈ 
• 898831-70-4 ((1S,2R,3R,4S,5R,6S)-5,6-diazidocyclohexane-1,2,3,4-tetrayl)tetrakis(oxy)tetrakis(methylene)tetrabenzene 
• 24558-77-8 3,4,5,6-tetra-O-benzyl inositol 

Relevant academic research and scientific papers

The myo-1,2-diaminocyclitol scaffold defines potent glucocerebrosidase activators and promising pharmacological chaperones for gaucher disease

A series of cyclitol derivatives with myo-configuration are β-glucocerebrosidase (GCase) inhibitors and show excellent characteristics for the development of pharmacological chaperones for enzyme deficiency in Gaucher disease (GD). The most potent inhibit

Enantio- and diastereodivergent synthetic route to multifarious cyclitols from D-xylose via ring-closing metathesis

Short stereoselective syntheses of various cyclitols, including the derivatives of conduritol B, conduritol F, myo-inositol, and chiro-inositol have been accomplished. The key steps in the syntheses are a ring-closing metathesis process and a diastereodiv

Synthesis of cyclitols via ring-closing metathesis

A convenient synthesis of enantiomerically pure and differentially protected L-chiro- and myo-inositols as well as conduritols B and F from 2,3,4-tri-O-benzyl-D-xylopyranose via ring-closing metathesis is reported. The facile synthesis of conduritol B con

Synthesis of Optically Active Inositol Derivatives Starting from D-Glucurono-6,3-lactone

D-Glucurono-6,3-lactone was converted to optically active and partially protected inositols.The synthetic strategy involves an efficient conversion of the D-gluco configuration to the L-ido configuration and dials to cyclitols.